Sinovac Biotech, Ltd. · NASDAQ:SVA
Sinovac Biotech — Investor Presentation (June 2025)
21 slides from Sinovac Biotech's investor presentation, Jun 24, 2025
Slide 1: Restore Fairness and Deliver Value to All SINOVAC Shareholders
Restore Fairness and Deliver Value to All SINOVAC Shareholders Official communication from the Sinovac Biotech Ltd. Board of Directors, June 2025
Slide 2: Safe Harbor Statement
Safe Harbor Statement This presentation and related materials contain forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be
Slide 3: We Are at a Critical Juncture for SINOVAC
We Are at a Critical Juncture for SINOVAC SAIF has called a Special Meeting of Shareholders to ask SINOVAC shareholders to vote to reconstitute a remnant of the Former Board, which presided over seven years of ignoring or harming your rights and economic interests. The UK Privy Council, in an unappe
Slide 4: Protect Your Rights as a Shareholder by Standing with the Current SINOVAC Board
Protect Your Rights as a Shareholder by Standing with the Current SINOVAC Board at the Special Meeting • Do not take the bait and be distracted by the Dissenting Investor Group’s hostile actions and false claims. It’s the same scheme – this time dressed up as a Special Meeting. • Advantech/Prime and
Slide 5: The SINOVAC Board is Focused on Restoring Fairness and Delivering Immediate Value
The SINOVAC Board is Focused on Restoring Fairness and Delivering Immediate Value to Shareholders 1 2 3 4 Declaration of Dividends Resumption of Good Protecting Valid Strategic Realignment to return an appropriate share Relations with NASDAQ SINOVAC Shareholders for Shareholder Value of distribution
Slide 6: Check the Dividend Scoreboard Before You Vote!
1 Check the Dividend Scoreboard Before You Vote! Current SINOVAC Board Imposter Former Board Dividend US$74.00 / share US$0 Commitments within four months(1) during a more (up to US$138.73 including than 7-year period additional potential payouts(2)) SINOVAC’s Valid SAIF Supporters Shareholders Dist
Slide 7: Declaration of Dividends
1 Declaration of Dividends Instead, in just four months since being installed following the Privy Council ruling, the current SINOVAC Board has already demonstrated commitment to dividends by: SAIF’s proxy statement says it is in favor of dividends, but • Declaring a US$55.00 per common share specia
Slide 8: Resumption of Good Relations with NASDAQ
The facts: 2 Resumption of In 2018, the Imposter Former Board triggered the unlawful poison pill and issued Good Relations dilutive shares, directly causing the NASDAQ trading halt in February 2019. with NASDAQ These same directors presided over sham transactions and material weaknesses in financial
Slide 9: Protecting Valid SINOVAC Shareholders and Paying Dividends in the Face of Continuous Lawfare
3 Protecting Valid SINOVAC Shareholders and Paying Dividends in the Face of Continuous Lawfare Waged by Advantech/Prime and Vivo Capital • SINOVAC has been saddled with multiple lawsuits since 2018 because of the shady self-dealing of Advantech/Prime, Vivo Capital and certain other members of the fo
Slide 10: Strategic Realignment for Shareholder Value Creation
4 Strategic Realignment for Shareholder Value Creation • In four short months since being installed by the Privy Council ruling, the current SINOVAC Board has taken bold steps to cancel invalid transactions undertaken by the very directors SAIF seeks to reseat and break a multi-year pattern of self-
Slide 11: Appendix
Appendix | 11
Slide 12: Illustrative Potential Dividends to SINOVAC Shareholders
Illustrative Potential Dividends to SINOVAC Shareholders Distribution of excess cash from the Company US$20.00 - US$50.00 Only the current SINOVAC Board can Recovery of escrowed dividends assigned to get you these recovery funds. The Dissenting Investor Group’s invalid PIPE shares US$14.73 SAIF Reco
Slide 13: The Dissenting Investor Group's Most Recent Attempt to Interfere With the US$55.00 Dividend
The Dissenting Investor Group’s Most Recent Blatant Attempt to Interfere With Your Receipt of the US$55.00 Dividend • On June 12, 2025, Advantech/Prime filed a Petition for Emergency Injunctive Relief against SINOVAC, OrbiMed and 1Globe Capital, naming as relief parties Cede & Co., The Depository Tr
Slide 14: History of the Dissenting Investor Group's Hostile Actions
History of the Dissenting Investor Group’s Hostile Actions 2016-2017: July 2018: PIPE Investment 2020: Exploitation for Profit 2025: Blocking Privatization Push Power Grab The Dissenting Investor Group exploited SINOVAC by Shareholder Payouts The Dissenting Investor The Dissenting Investor Group iss
Slide 15: Invalid PIPE Investment Was a Blatant Act of Self-Dealing
Invalid PIPE Investment Was a Blatant Act of Self-Dealing By the Dissenting Investor Group Advantech/Prime and Vivo Capital are not legitimate SINOVAC shareholders. Their ownership is the result of an invalid PIPE transaction, which is in the process of being unwound. • In July 2018, the Imposter Fo
Slide 16: Egregious Scheme to Steal Value with Gifted Shares of SINOVAC's Operating Subsidiary
Egregious Scheme to Steal Value with Gifted Shares of SINOVAC’s Operating Subsidiary Implied Valuations of SLS • Development of CoronaVac by SINOVAC's subsidiary Sinovac Life Sciences ("SLS") was well underway in January 2020 and the US$100 million US$3,400 million Company was well capitalized to fu
Slide 17: Additional Governance Failures of the Imposter Former Board
Additional Governance Failures of the Imposter Former Board In addition to the PIPE transaction and the SLS investment, the current SINOVAC Board has identified several additional governance failures by the Imposter Former Board, including: • Share grants to select minority shareholders. • Excessive
Slide 18: The Imposter Former Board Directly Caused the Departure of SINOVAC's Auditor
The Imposter Former Board Directly Caused the Departure of SINOVAC’s Auditor The Dissenting Investor Group’s Myth: The Company’s former auditor, Grant Thornton, resigned because of actions by the current SINOVAC Board. The Reality: Grant Thornton stated its resignation was not the result of any disa
Slide 19: Examination of the Imposter Former Board's Financial Missteps and Grant Thornton's Resignation
A Detailed Examination of the Imposter Former Board’s Financial Missteps and Grant Thornton’s Resignation March 28, 2025 Sven H. Borho was appointed new Chair of the Board’s Audit Committee. April 4, 2025 SINOVAC’s Management informed the new Audit Committee Chair that the Company’s 2024 draft finan
Slide 20: Vote AGAINST the Proposal to Remove the SINOVAC Board
Vote AGAINST the Proposal to Remove the SINOVAC Board Your vote is critical to SINOVAC’s future. We urge you to keep SINOVAC’s Board in place and vote on the WHITE proxy card “AGAINST” Proposal 1 to remove the current SINOVAC Board and “AGAINST” Proposal 2 to appoint the Reconstitued Imposter Former
Slide 21: SINOVAC iA
SINOVAC iA